Title

Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes.

Document Type

Journal Article

Publication Date

3-7-2018

Journal

Steroids

DOI

10.1016/j.steroids.2018.02.010

Peer Reviewed

1

Find in your library

Share

COinS